 |
|
Rash in Psychiatric and Nonpsychiatric Adolescent Patients Receiving Lamotrigine in Korea: A Retrospective Cohort Study
Hee-Jong Tak, Joon-Ho Ahn, Kun-Woo Kim, Yeni Kim, Sam-Wook Choi, Kyung-Yeon Lee, Eun Jin Park, Soo-Young Bhang
Psychiatry Investig. 2012;9(2):174-179. Published online 2012 Apr 30 DOI: https://doi.org/10.4306/pi.2012.9.2.174
|
|
A new rapid titration protocol for lamotrigine that reduces the risk of skin rash
Yoonhyuk Jang, Jangsup Moon, Narae Kim, Tae‐Joon Kim, Jin‐Sun Jun, Yong‐Won Shin, Hyeyeon Chang, Hye‐Ryun Kang, Soon‐Tae Lee, Keun‐Hwa Jung, Kyung‐Il Park, Ki‐Young Jung, Kon Chu, Sang Kun Lee
Epilepsia Open.2021; 6(2): 394. CrossRef Safety of Long-term Use of Lamotrigine for the Treatment of Psychiatric Disorders
Rintaro Sogawa, Sakiko Mochinaga, Takayoshi Inaba, Jun Matsushima, Yoshito Mizoguchi, Toshiro Kawashima, Hiroshi Fujito, Akira Monji
Clinical Neuropharmacology.2016; 39(6): 295. CrossRef Lamotrigine Treatment of Adolescents with Unipolar and Bipolar Depression: A Retrospective Chart Review
Seung-Hyun Shon, Yeonho Joo, Jung-Sun Lee, Hyo-Won Kim
Journal of Child and Adolescent Psychopharmacology.2014; 24(5): 285. CrossRef Dermatologic Side Effects of Psychotropic Medications
Mario V. Mitkov, Ryan M. Trowbridge, Benjamin N. Lockshin, Jason P. Caplan
Psychosomatics.2014; 55(1): 1. CrossRef
|